Paolini John F.
SEC insider (Form 3/4/5 filer). CIK 0001741533. CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 61 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in LONDON.
Companies Paolini John F. has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF MEDICAL OFFICER
Paolini John F.
CIK: 0001741533
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (61 total)
- Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.5K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.8K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
6.7K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
26.8K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.5K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect4K shares at avg. $79.28$319K - May 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect58.4K shares at avg. $10.36$605K - May 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect21.1K shares at avg. $54.04$1.1M - May 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect37.3K shares at avg. $53.52$2.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,497 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,750 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 6,700 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 26,750 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,624 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,457 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 4,029 | $79.28 | $319,419 | Direct |
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 58,424 | $10.36 | $605,273 | Direct |
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 21,097 | $54.04 | $1,140,082 | Direct |
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 37,327 | $53.52 | $1,997,741 | Direct |
1-10 of 61 transactions